24th Jun 2013 07:00
Hutchison China MediTech Limited ("Chi-Med")
(AIM: HCM)
Notice of Announcement of 2013 Interim Results
London: Monday, 24 June 2013: Chi-Med will be announcing its interim results for the six months ended 30 June 2013 on Tuesday, 30 July 2013. An analyst presentation will be held at 9:00am on the same day at Citigate Dewe Rogerson, 3 London Wall Buildings, London, EC2M 5SY.
Ends
Enquiries
Chi-Med Christian Hogg, CEO | Telephone: +852 2121 8200 |
Panmure Gordon (UK) LimitedRichard GrayAndrew PottsGrishma Patel
| Telephone: +44 20 7886 2500 |
Citigate Dewe RogersonAnthony CarlisleDavid Dible | Telephone: +44 20 7638 9571Mobile: +44 7973 611 888Mobile: +44 7967 566 919 |
About Chi-Med
Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.
Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.
Related Shares:
Hutchmed